Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia
- PMID: 28239312
- PMCID: PMC5323308
- DOI: 10.5217/ir.2017.15.1.5
Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia
Conflict of interest statement
Conflict of interest: None.
Comment on
- Intest Res. 15:97.
Similar articles
-
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases.Intest Res. 2020 Jan;18(1):18-33. doi: 10.5217/ir.2019.09155. Epub 2020 Jan 30. Intest Res. 2020. PMID: 32013312 Free PMC article. Review.
-
Infections and inflammatory bowel disease: challenges in Asia.J Dig Dis. 2013 Nov;14(11):567-73. doi: 10.1111/1751-2980.12091. J Dig Dis. 2013. PMID: 23875824 Review.
-
Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.Aliment Pharmacol Ther. 2010 Jan;31(1):20-34. doi: 10.1111/j.1365-2036.2009.04112.x. Aliment Pharmacol Ther. 2010. PMID: 19681818 Review.
-
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection.J Viral Hepat. 2013 Mar;20(3):200-8. doi: 10.1111/j.1365-2893.2012.01643.x. Epub 2012 Jul 30. J Viral Hepat. 2013. PMID: 23383659
-
Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.Aliment Pharmacol Ther. 2005 Aug 1;22(3):209-15. doi: 10.1111/j.1365-2036.2005.02556.x. Aliment Pharmacol Ther. 2005. PMID: 16091058
Cited by
-
Vaccination strategies for Korean patients with inflammatory bowel disease.Korean J Intern Med. 2022 Sep;37(5):920-930. doi: 10.3904/kjim.2022.149. Epub 2022 Aug 8. Korean J Intern Med. 2022. PMID: 35934888 Free PMC article. Review.
-
Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea.Intest Res. 2018 Oct;16(4):599-608. doi: 10.5217/ir.2018.00012. Epub 2018 Oct 10. Intest Res. 2018. PMID: 30301330 Free PMC article.
References
-
- Biancone L, Pavia M, Del Vecchio Blanco G, et al. Hepatitis B and C virus infection in Crohn's disease. Inflamm Bowel Dis. 2001;7:287–294. - PubMed
-
- Forns X, Martínez-Bauer E, Feliu A, et al. Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology. 2005;41:115–122. - PubMed
-
- Salcedo-Mora X, Maté J, Medina J, Nam Cha SJ, Gisbert JP, Moreno-Otero R. Chronic hepatitis C and Crohn's disease: nosocomial infection treatment with PEG-interferon plus ribavirin. Digestion. 2006;73:210–214. - PubMed
-
- Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol. 2009;104:57–63. - PubMed
-
- Chevaux JB, Nani A, Oussalah A, et al. Prevalence of hepatitis B and hepatitis C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis. 2010;16:916–924. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources